News Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-27 EDT			5-day change	1st Jan Change
479.00 ^USD	+0.34%		-1.37%	+5.66%

07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT
07-20	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT

11a51730697f75b3fe18aa52474161.PcxNSK3vlzRRKhOA7wWVNZZ6wnDTUUhz9f5iZW0It7k.bIM1EZu79Ewnb0G0t1bwQa5NuEaVMAQKusY6ITxthd91myEsy6rmAxVlKw~c52d45e51dd6cb67d877a109a8acdf77